0 followers
Treovir’s G207 Therapy demonstrated improved survival in a Phase 1 study without any serious side effects. Treovir strives to change the course of brain tumor therapies, improve survival rates and quality of life and provide hope.
Industries
Headquarters
Employees
Links
Michael Christini
3 members
2 members
Coherus BioSciences
5 followers
ONI
6 followers
BioMarin Pharmaceutical
21 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies